FDA panel recommends Moderna Booster for certain group

Some experts doubt whether Moderna has collected enough data on possible side effects. Regulators and scientists are particularly concerned about the risk of heart disease, myocarditis, or inflammation of the heart muscle, and pericarditis, or inflammation of the lining of the heart.

The FDA warned of this risk for Pfizer BioEntech and Moderna vaccines in June, and officials on Thursday reported a higher risk in men between the ages of 18 and 25 being treated with Moderna or Pfizer BioEntech. vaccinated by

Much of Thursday’s discussion revolved around Israel’s push for a Pfizer BioNTech vaccine. The Biden government is closely monitoring Israel’s experience because it has a national health system that allows it to closely monitor vaccine recipients.

A senior Israeli health official told the committee that his government-strengthening campaign had changed the course of the pandemic there. He said Israel saw drastically lower infections and serious illnesses in people who had not received the booster. However, it’s not clear if other factors, such as a delta downgrade, are also having an impact.

Mark Sawyer, a professor at the University of San Diego California School of Medicine, said that while the Moderna vaccine is different, the Israeli data are interesting.

dr. However, Kurila of the National Institutes of Health questioned whether Israel’s stimulus campaign deserves much credit, noting that the country’s recent decline in the number of infected people appears to be in line with previous waves of the virus.

He met with Israel’s Director of Public Health, Dr. Sharon Alroy-Price on whether she believes a third shot of Pfizer’s vaccine will extend long-term protection or whether you’ll be back “in six months” for a new booster.

dr. Alroy Price suggests that some vaccines will protect for years after a booster. Whether this applies to a coronavirus vaccine is a “million dollar question,” he said.